Intriguingly, no matter what endpoint events were considered in survival analyses, involving OS, DSS, DFI, and PFI, high-STMN1 expression tend to lead to poorer prognosis in HCC patients (Supplementary Fig. S7C). The gene discussed is STMN1; the disease is hepatocellular carcinoma.